IT1208509B - Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico. - Google Patents
Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.Info
- Publication number
- IT1208509B IT1208509B IT8519885A IT1988585A IT1208509B IT 1208509 B IT1208509 B IT 1208509B IT 8519885 A IT8519885 A IT 8519885A IT 1988585 A IT1988585 A IT 1988585A IT 1208509 B IT1208509 B IT 1208509B
- Authority
- IT
- Italy
- Prior art keywords
- sulphate
- dermatan
- eparan
- production
- pharmaceutical use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0066—Isolation or extraction of proteoglycans from organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8519885A IT1208509B (it) | 1985-03-13 | 1985-03-13 | Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico. |
DE86102963T DE3689493T2 (de) | 1985-03-13 | 1986-03-06 | Verfahren zur Herstellung von reinem natürlichen Heparansulfat und Dermatansulfat und ihre pharmazeutische Verwendung. |
EP86102963A EP0199033B1 (en) | 1985-03-13 | 1986-03-06 | Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use |
AT86102963T ATE99702T1 (de) | 1985-03-13 | 1986-03-06 | Verfahren zur herstellung von reinem natuerlichen heparansulfat und dermatansulfat und ihre pharmazeutische verwendung. |
US06/838,133 US4783447A (en) | 1985-03-13 | 1986-03-10 | Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use |
NZ215435A NZ215435A (en) | 1985-03-13 | 1986-03-11 | Preparation of heparan sulphate and dermatan sulphate |
ES552898A ES8705894A1 (es) | 1985-03-13 | 1986-03-12 | Procedimiento para producir heparan sulfato natural y dermatan sulfato en forma sustancialmente pura |
PH33516A PH22370A (en) | 1985-03-13 | 1986-03-12 | Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form |
NO860940A NO166187C (no) | 1985-03-13 | 1986-03-12 | Fremgangsmaate for fremstilling av naturlig heparansulfat og dermatansulfat i hovedsakelig ren form. |
GR860677A GR860677B (en) | 1985-03-13 | 1986-03-12 | Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form and their pharmaceutical use |
FI861020A FI82700C (fi) | 1985-03-13 | 1986-03-12 | Foerfarande foer framstaellning av naturligt heparansulfat och dermatansulfat i vaesentligen ren form. |
IN184/CAL/86A IN163616B (it) | 1985-03-13 | 1986-03-12 | |
DK113886A DK113886A (da) | 1985-03-13 | 1986-03-12 | Fremgangsmaade til fremstilling af heparansulfat og dermatansulfat ogfarmaceutisk anvendelse af disse stoffer |
ZA861855A ZA861855B (en) | 1985-03-13 | 1986-03-12 | Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form,and their pharmaceutical use |
CA000503943A CA1286286C (en) | 1985-03-13 | 1986-03-12 | Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use |
PT82198A PT82198B (pt) | 1985-03-13 | 1986-03-13 | Processo de producao de sulfato de heparano e sulfato de dermatano, naturais, em forma substancialmente pura e de composicoes farmaceuticas que os contem |
KR1019860001805A KR910006809B1 (ko) | 1985-03-13 | 1986-03-13 | 천연 헤파란 설페이트 및 더머탄 설페이트의 제조방법 |
JP61053838A JPS61218601A (ja) | 1985-03-13 | 1986-03-13 | 実質上、純粋な形状の、天然のヘパラン硫酸およびデルマタン硫酸の製造法およびそれらの医薬的使用 |
AU54727/86A AU582221B2 (en) | 1985-03-13 | 1986-03-13 | Process for producing natural heparan sulphate in substantially pure form,and their pharmaceutical use |
YU37586A YU46303B (sh) | 1985-03-13 | 1986-03-13 | Postupak za proizvodnju prirodnog heparan-sulfata i dermatan-sulfata u suštinski čistom obliku |
PH35381A PH25136A (en) | 1985-03-13 | 1987-06-10 | Natural heparan sulphate and dermatan sulphate in substantially pure form and method of use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8519885A IT1208509B (it) | 1985-03-13 | 1985-03-13 | Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico. |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8519885A0 IT8519885A0 (it) | 1985-03-13 |
IT1208509B true IT1208509B (it) | 1989-07-10 |
Family
ID=11162062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT8519885A IT1208509B (it) | 1985-03-13 | 1985-03-13 | Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico. |
Country Status (20)
Country | Link |
---|---|
US (1) | US4783447A (it) |
EP (1) | EP0199033B1 (it) |
JP (1) | JPS61218601A (it) |
KR (1) | KR910006809B1 (it) |
AT (1) | ATE99702T1 (it) |
AU (1) | AU582221B2 (it) |
CA (1) | CA1286286C (it) |
DE (1) | DE3689493T2 (it) |
DK (1) | DK113886A (it) |
ES (1) | ES8705894A1 (it) |
FI (1) | FI82700C (it) |
GR (1) | GR860677B (it) |
IN (1) | IN163616B (it) |
IT (1) | IT1208509B (it) |
NO (1) | NO166187C (it) |
NZ (1) | NZ215435A (it) |
PH (2) | PH22370A (it) |
PT (1) | PT82198B (it) |
YU (1) | YU46303B (it) |
ZA (1) | ZA861855B (it) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1189085B (it) * | 1986-03-25 | 1988-01-28 | Mediolanum Farmaceutici Srl | Processo per la preparazione di dermatan solfato ad alta purezza e composizioni farmaceutiche che lo contengono |
US5707604A (en) * | 1986-11-18 | 1998-01-13 | Access Pharmaceuticals, Inc. | Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
DE3639561A1 (de) * | 1986-11-20 | 1988-06-01 | Baumann Hanno | Verfahren zur herstellung von nicht-thrombogenen substraten |
IT1232939B (it) * | 1987-11-06 | 1992-03-10 | Opocrin Spa | Eparan solfato caratterizzato da elevata attivita' antitrombotica, elevata biodisponibilita', assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche |
AU630359B2 (en) * | 1988-06-03 | 1992-10-29 | Italfarmaco S.P.A. | Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them |
IE64121B1 (en) * | 1989-10-04 | 1995-07-12 | Akzo Nv | Sulphated glycosaminoglycuronan with antithrombotic activity |
AU6872691A (en) * | 1989-10-27 | 1991-05-31 | Case Western Reserve University | Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
IT1240615B (it) * | 1990-04-03 | 1993-12-17 | Mediolanum Farmaceutici Spa | Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale |
WO1991015217A1 (en) * | 1990-04-06 | 1991-10-17 | Washington University | Anticoagulant oligosaccharides |
US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
US5705178A (en) * | 1991-05-31 | 1998-01-06 | Gliatech, Inc. | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
FR2691066B1 (fr) * | 1992-05-15 | 1995-06-09 | Sanofi Elf | Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies. |
IT1256236B (it) * | 1992-12-23 | 1995-11-29 | Mediolanum Farmaceutici Srl | Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani |
CA2150552C (en) * | 1993-09-30 | 1999-12-21 | Akikazu Takada | Antithrombotic |
US6106866A (en) * | 1995-07-31 | 2000-08-22 | Access Pharmaceuticals, Inc. | In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites |
IT1296581B1 (it) * | 1997-11-28 | 1999-07-14 | Istituto Scient Di Chimica E B | Materiali polimerici non trombogenici e ad esaltata compatibilita' con fluidi e tessuti organici |
BR0012202A (pt) * | 1999-06-30 | 2002-04-02 | Hamilton Civic Hospitals Res | Composições de heparina de peso molecular médio (mmwh), método de tratamento de uma condição trombótica, método de prevenção da formação de um trombo, método de inibição da formação de trombos, composição farmacêutica, método de tratamento de trombose venosa profunda, método de prevenção de embolia pulmonar, método de preparação e usos de uma composição de mmwh |
KR20030069990A (ko) * | 2000-09-08 | 2003-08-27 | 해밀톤 시빅 호스피탈즈 리서치 디벨로프먼트 인코포레이티드 | 항혈전 조성물 |
CN107098989A (zh) * | 2017-04-27 | 2017-08-29 | 甘肃省金羚集团药业有限公司 | 一种肝素钠的制备方法 |
CN114478832B (zh) * | 2022-02-14 | 2023-03-03 | 河北常山生化药业股份有限公司 | 从肝素钠副产物中提纯四种多糖类产品的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3179566A (en) * | 1963-05-16 | 1965-04-20 | Canada Packers Ltd | Purification of heparin |
JPS5318520B2 (it) * | 1972-07-05 | 1978-06-15 | ||
AR207237A1 (es) * | 1974-02-25 | 1976-09-22 | Thomas A | Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes |
US4243582A (en) * | 1979-04-26 | 1981-01-06 | Monsanto Company | Novel glycoproteins from bovine cartilage |
JPS58171403A (ja) * | 1982-04-01 | 1983-10-08 | Eisai Co Ltd | ヘパラン硫酸の精製法 |
IT1189298B (it) * | 1982-06-18 | 1988-02-04 | Manetti & Roberts Italo Brit | Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico |
FR2555993B1 (fr) * | 1983-12-06 | 1986-11-07 | Anic Spa | Chitosanes 6-sulfates et procede pour leur preparation |
IT1195497B (it) * | 1983-03-08 | 1988-10-19 | Opocrin Spa | Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina |
IT1163772B (it) * | 1983-07-13 | 1987-04-08 | Baldacci Lab Spa | Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche |
-
1985
- 1985-03-13 IT IT8519885A patent/IT1208509B/it active
-
1986
- 1986-03-06 AT AT86102963T patent/ATE99702T1/de not_active IP Right Cessation
- 1986-03-06 DE DE86102963T patent/DE3689493T2/de not_active Expired - Fee Related
- 1986-03-06 EP EP86102963A patent/EP0199033B1/en not_active Expired - Lifetime
- 1986-03-10 US US06/838,133 patent/US4783447A/en not_active Expired - Fee Related
- 1986-03-11 NZ NZ215435A patent/NZ215435A/xx unknown
- 1986-03-12 NO NO860940A patent/NO166187C/no unknown
- 1986-03-12 IN IN184/CAL/86A patent/IN163616B/en unknown
- 1986-03-12 FI FI861020A patent/FI82700C/fi not_active IP Right Cessation
- 1986-03-12 CA CA000503943A patent/CA1286286C/en not_active Expired - Fee Related
- 1986-03-12 DK DK113886A patent/DK113886A/da not_active Application Discontinuation
- 1986-03-12 GR GR860677A patent/GR860677B/el unknown
- 1986-03-12 ES ES552898A patent/ES8705894A1/es not_active Expired
- 1986-03-12 ZA ZA861855A patent/ZA861855B/xx unknown
- 1986-03-12 PH PH33516A patent/PH22370A/en unknown
- 1986-03-13 PT PT82198A patent/PT82198B/pt unknown
- 1986-03-13 AU AU54727/86A patent/AU582221B2/en not_active Ceased
- 1986-03-13 KR KR1019860001805A patent/KR910006809B1/ko not_active IP Right Cessation
- 1986-03-13 YU YU37586A patent/YU46303B/sh unknown
- 1986-03-13 JP JP61053838A patent/JPS61218601A/ja active Granted
-
1987
- 1987-06-10 PH PH35381A patent/PH25136A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE3689493T2 (de) | 1994-04-28 |
IN163616B (it) | 1988-10-15 |
ATE99702T1 (de) | 1994-01-15 |
DK113886D0 (da) | 1986-03-12 |
DE3689493D1 (de) | 1994-02-17 |
CA1286286C (en) | 1991-07-16 |
KR860007278A (ko) | 1986-10-10 |
IT8519885A0 (it) | 1985-03-13 |
ZA861855B (en) | 1986-10-29 |
PH25136A (en) | 1991-02-19 |
KR910006809B1 (ko) | 1991-09-02 |
AU5472786A (en) | 1986-09-18 |
EP0199033A3 (en) | 1988-03-30 |
AU582221B2 (en) | 1989-03-16 |
EP0199033A2 (en) | 1986-10-29 |
FI82700C (fi) | 1991-04-10 |
YU46303B (sh) | 1993-05-28 |
JPS61218601A (ja) | 1986-09-29 |
ES8705894A1 (es) | 1987-05-16 |
US4783447A (en) | 1988-11-08 |
DK113886A (da) | 1986-09-14 |
PH22370A (en) | 1988-08-12 |
EP0199033B1 (en) | 1994-01-05 |
FI82700B (fi) | 1990-12-31 |
NO166187C (no) | 1991-06-12 |
GR860677B (en) | 1986-07-14 |
YU37586A (en) | 1988-04-30 |
FI861020A (fi) | 1986-09-14 |
PT82198B (pt) | 1988-02-17 |
PT82198A (en) | 1986-04-01 |
JPH0238601B2 (it) | 1990-08-31 |
NO166187B (no) | 1991-03-04 |
FI861020A0 (fi) | 1986-03-12 |
NZ215435A (en) | 1989-01-06 |
NO860940L (no) | 1986-09-15 |
ES552898A0 (es) | 1987-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1208509B (it) | Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico. | |
ATE81672T1 (de) | Ein durch xanthomonas hergestelltes polysaccharidpolymer. | |
AU7688396A (en) | Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates | |
NZ333925A (en) | Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus | |
ES2048974T3 (es) | Aparato para producir continuamente agua electrolizada. | |
ES2180161T3 (es) | Glicosaminoglicanos con alta actividad antitrombotica in vitro. | |
IT1189298B (it) | Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico | |
AU3742495A (en) | Method of producing starch decomposition products | |
NZ325259A (en) | Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments | |
DE68914236D1 (de) | Verfahren zur Herstellung von Natriumhyaluronat durch Gärung. | |
IT1251182B (it) | Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche. | |
IT8948551A0 (it) | Procedimento per la produzione di analgesia in mammiferi. | |
ATE332706T1 (de) | Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen | |
BG105326A (en) | Novel benzoylguanadine derivatives with advantageous properties, method for producing them and their use in the production of medicaments | |
ATE261438T1 (de) | Produkte für körperhygiene basierend auf lapacho extrakte enthaltend quercetin, deren herstellung und verwendung | |
CA2348767A1 (en) | Method for producing an antitumoral agent and antitumoral agent thus obtained | |
BG102009A (en) | Method for the treatment of manic and two-pole disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19940330 |